GPT-5 lowers the cost of cell-free protein synthesis
OpenAI Blog
OpenAI's GPT-5 integrated with Ginkgo Bioworks' cloud automation platform optimized cell-free protein synthesis through repeated cycles of design and testing. The cost of production decreased by 40% compared to baseline methods. This reduction enables cheaper development of custom proteins for pharmaceutical and biotechnology applications.
Why it matters
An autonomous lab combining OpenAI’s GPT-5 with Ginkgo Bioworks’ cloud automation cut cell-free protein synthesis costs by 40% through closed-loop experimentation.